Man Hong Tam
Director of Finance/CFO at QuantumPharm, Inc.
Profile
Mr. Man Hong Tam is a Chief Financial Officer & Joint Secretary at QuantumPharm, Inc. and a Member at Hong Kong Institute of Certified Public Accountants.
Mr. Tam was previously employed as a Chief Financial Officer by HUYA Bioscience International LLC, a Managing Director by UBS AG, a Managing Director by BOSC International Co. Ltd., a Managing Director by Guosen Securities (HK) Financial Holdings Co., Ltd., and a Managing Director by Jefferies Hong Kong Ltd.
He also served on the board at UBS AG (Hong Kong Branch).
He received his undergraduate degree from Auckland University and a graduate degree from the University of Cambridge.
Man Hong Tam active positions
Companies | Position | Start |
---|---|---|
QuantumPharm, Inc.
QuantumPharm, Inc. Miscellaneous Commercial ServicesCommercial Services QuantumPharm, Inc. operates as a holding company with interests in drug research and development services. It engages in the business relating to drug discovery solutions including one-stop drug discovery solutions and automated chemical synthesis services and intelligent automation services. The company was founded by Lai Li Ppeng, Ma Jian and Wen Shu Hao in 2015 and is headquartered in Shenzhen, China. | Director of Finance/CFO | 2020-11-30 |
Hong Kong Institute of Certified Public Accountants
Hong Kong Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Hong Kong Institute of Certified Public Accountants operates under the professional accountant’s ordinance and works in the public interest. It offers CPA qualification programme and promulgating financial reporting, auditing and ethical standards in Hong Kong. The company was founded on January 1, 1973 and is headquartered in Hong Kong. | Corporate Officer/Principal | 2002-12-31 |
Former positions of Man Hong Tam
Companies | Position | End |
---|---|---|
HUYA Bioscience International LLC
HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Director of Finance/CFO | 2020-10-31 |
UBS | Chief Executive Officer | 2020-06-30 |
BOSC International Co. Ltd.
BOSC International Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Bank of Shanghai Co., Ltd., BOSC International Co. Ltd. provides financial consulting services. The company is based in Hong Kong, Hong Kong. The CEO of the Chinese company is Chi Wah Lau. | Chief Executive Officer | 2018-04-30 |
Guosen Securities (HK) Financial Holdings Co., Ltd. | Chief Executive Officer | 2016-12-31 |
Jefferies Hong Kong Ltd.
Jefferies Hong Kong Ltd. Investment Banks/BrokersFinance Jefferies Hong Kong Ltd. is a securities brokerage firm headquartered in Hong Kong. The firm is a subsidiary of Jefferies Group LLC, which is owned by Jefferies Financial Group, Inc. (NYSE: JEF) in the US. Jefferies Hong Kong is a client-focused full-service sales, trading and capital markets platform across all equity and fixed income securities. They provide an array of trading and execution services for their clients. | Chief Executive Officer | 2015-10-31 |
Training of Man Hong Tam
Auckland University | Undergraduate Degree |
University of Cambridge | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 8 |
---|---|
QuantumPharm, Inc.
QuantumPharm, Inc. Miscellaneous Commercial ServicesCommercial Services QuantumPharm, Inc. operates as a holding company with interests in drug research and development services. It engages in the business relating to drug discovery solutions including one-stop drug discovery solutions and automated chemical synthesis services and intelligent automation services. The company was founded by Lai Li Ppeng, Ma Jian and Wen Shu Hao in 2015 and is headquartered in Shenzhen, China. | Commercial Services |
UBS AG (Hong Kong Branch)
UBS AG (Hong Kong Branch) Investment Banks/BrokersFinance Part of UBS Group AG, UBS AG (Hong Kong Branch) is a Chinese company that provides investment banking securities dealing services. The company is based in Hong Kong, Hong Kong. | Finance |
Jefferies Hong Kong Ltd.
Jefferies Hong Kong Ltd. Investment Banks/BrokersFinance Jefferies Hong Kong Ltd. is a securities brokerage firm headquartered in Hong Kong. The firm is a subsidiary of Jefferies Group LLC, which is owned by Jefferies Financial Group, Inc. (NYSE: JEF) in the US. Jefferies Hong Kong is a client-focused full-service sales, trading and capital markets platform across all equity and fixed income securities. They provide an array of trading and execution services for their clients. | Finance |
Guosen Securities (HK) Financial Holdings Co., Ltd. | |
BOSC International Co. Ltd.
BOSC International Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Bank of Shanghai Co., Ltd., BOSC International Co. Ltd. provides financial consulting services. The company is based in Hong Kong, Hong Kong. The CEO of the Chinese company is Chi Wah Lau. | Commercial Services |
UBS AG
UBS AG Investment ManagersFinance UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded in 1862 and is headquartered in Zurich, Switzerland. | Finance |
HUYA Bioscience International LLC
HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Health Technology |
Hong Kong Institute of Certified Public Accountants
Hong Kong Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Hong Kong Institute of Certified Public Accountants operates under the professional accountant’s ordinance and works in the public interest. It offers CPA qualification programme and promulgating financial reporting, auditing and ethical standards in Hong Kong. The company was founded on January 1, 1973 and is headquartered in Hong Kong. | Commercial Services |
- Stock Market
- Insiders
- Man Hong Tam